$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000087786024000010 Filed on February 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$81.51M	$79.47M	$319.8M
YoY Change	-1.06%	12.45%	14.97%
Cost Of Revenue	$13.05M	$12.84M	$51.10M
YoY Change	5.07%	6.3%	34.54%
Gross Profit	$68.47M	$66.63M	$268.7M
YoY Change	-2.15%	13.71%	11.87%
Gross Profit Margin	83.99%	83.85%	84.02%
Selling, General & Admin	$5.691M	$5.073M	$20.27M
YoY Change	-4.48%	-4.75%	-22.54%
% of Gross Profit	8.31%	7.61%	7.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.51M	$17.07M	$69.97M
YoY Change	-0.64%	-1.33%	-1.28%
% of Gross Profit	25.57%	25.62%	26.04%
Operating Expenses	$51.12M	$22.18M	$200.9M
YoY Change	3.06%	-1.97%	-16.94%
Operating Profit	$17.34M	$44.44M	$67.86M
YoY Change	-14.85%	23.58%	-4230.01%
Interest Expense	$14.87M	-$14.30M	$58.16M
YoY Change	6.0%	14.88%	29.48%
% of Operating Profit	85.73%	-32.17%	85.71%
Other Income/Expense, Net		$0.00	$202.0K
YoY Change
Pretax Income	$30.66M	$31.72M	$134.4M
YoY Change	-10.32%	1933.27%	105.16%
Income Tax
% Of Pretax Income
Net Earnings	$30.95M	$32.03M	$135.7M
YoY Change	-10.26%	1619.11%	104.29%
Net Earnings / Revenue	37.97%	40.3%	42.41%
Basic Earnings Per Share	$0.71		$3.13
Diluted Earnings Per Share	$0.71	$0.74	$3.13
COMMON SHARES
Basic Shares Outstanding	43.41M shares	43.41M shares	43.39M shares
Diluted Shares Outstanding	43.42M shares		43.39M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.36M	$22.35M	$22.35M
YoY Change	-18.15%	15.84%	15.84%
Cash & Equivalents	$11.36M	$22.35M	$22.35M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$7.927M	$4.916M	$4.916M
Other Receivables	$84.26M	$84.71M	$84.71M
Total Short-Term Assets	$103.5M	$112.0M	$112.0M
YoY Change	3.77%	16.42%	12.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.093B	$2.107B	$2.107B
YoY Change	-3.34%	-0.53%	-0.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.976M	$7.274M	$7.274M
YoY Change	-75.37%	-84.02%	-84.02%
Total Long-Term Assets	$2.375B	$2.377B	$2.377B
YoY Change	-2.42%	-1.44%	-1.29%
TOTAL ASSETS
Total Short-Term Assets	$103.5M	$112.0M	$112.0M
Total Long-Term Assets	$2.375B	$2.377B	$2.377B
Total Assets	$2.478B	$2.488B	$2.488B
YoY Change	-2.18%	-0.76%	-0.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.78M	$34.30M	$32.60M
YoY Change	8.75%	32.42%	25.84%
Accrued Expenses			$1.705M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$65.86M	$73.37M	$73.37M
YoY Change	3.44%	12.96%	12.96%
LONG-TERM LIABILITIES
Long-Term Debt	$1.139B	$1.135B	$1.135B
YoY Change	-3.12%	-1.09%	-1.09%
Other Long-Term Liabilities	$5.429M	$6.009M	$6.009M
YoY Change	9.81%	18.94%	18.94%
Total Long-Term Liabilities	$1.145B	$1.141B	$1.141B
YoY Change	-3.07%	-1.0%	-1.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$65.86M	$73.37M	$73.37M
Total Long-Term Liabilities	$1.145B	$1.141B	$1.141B
Total Liabilities	$1.211B	$1.214B	$1.235B
YoY Change	-2.74%	-0.25%	-0.22%
SHAREHOLDERS EQUITY
Retained Earnings	$2.498B	$2.467B
YoY Change	5.58%	5.82%
Common Stock	$1.606B	$1.604B
YoY Change	0.29%	0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.248B	$1.254B	$1.254B
YoY Change
Total Liabilities & Shareholders Equity	$2.478B	$2.488B	$2.488B
YoY Change	-2.18%	-0.76%	-0.76%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$30.95M	$32.03M	$135.7M
YoY Change	-10.26%	1619.11%	104.29%
Depreciation, Depletion And Amortization	$17.51M	$17.07M	$69.97M
YoY Change	-0.64%	-1.33%	-1.28%
Cash From Operating Activities	$40.83M	$53.25M	$184.5M
YoY Change	31.5%	14.87%	-0.48%
INVESTING ACTIVITIES
Capital Expenditures	$683.0K	$1.124M	$49.56M
YoY Change	-98.21%	-24.46%	350.8%
Acquisitions
YoY Change
Other Investing Activities	-$15.51M	$3.494M	$30.19M
YoY Change	-246.88%	-107.32%	-85.22%
Cash From Investing Activities	-$16.19M	$2.370M	-$11.63M
YoY Change	-41.16%	-104.82%	-105.88%
FINANCING ACTIVITIES
Cash Dividend Paid	$39.07M		$156.2M
YoY Change	0.05%		-3.42%
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net	$105.0K		$415.4M
YoY Change	-99.93%		206.84%
Cash From Financing Activities	-$35.92M	-49.42M	-$169.7M
YoY Change	277.49%	571.73%	-57.7%
NET CHANGE
Cash From Operating Activities	$40.83M	53.25M	$184.5M
Cash From Investing Activities	-$16.19M	2.370M	-$11.63M
Cash From Financing Activities	-$35.92M	-49.42M	-$169.7M
Net Change In Cash	-$11.29M	6.201M	$3.101M
YoY Change	88.48%	-160.81%	-117.26%
FREE CASH FLOW
Cash From Operating Activities	$40.83M	$53.25M	$184.5M
Capital Expenditures	$683.0K	$1.124M	$49.56M
Free Cash Flow	$40.14M	$52.13M	$134.9M
YoY Change	-670.79%	16.17%	-22.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-710000	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	134381000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	65501000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	111967000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1273000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-902000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	163000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	66403000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	111804000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#InvestmentBuildingAndBuildingImprovements
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#InvestmentBuildingAndBuildingImprovements
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-10822
CY2023	dei	Entity Registrant Name EntityRegistrantName	National Health Investors, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1470956
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	222 Robert Rose Drive
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Murfreesboro
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37129
CY2023	dei	City Area Code CityAreaCode	(615)
CY2023	dei	Local Phone Number LocalPhoneNumber	890-9100
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	NHI
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2165587000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43409841	shares
CY2023	dei	Auditor Name AuditorName	BDO USA, P.C.
CY2023	dei	Auditor Location AuditorLocation	Nashville, Tennessee
CY2023Q4	us-gaap	Land Land	180749000	usd
CY2022Q4	us-gaap	Land Land	177527000	usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2593696000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2549019000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	5913000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3352000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2780358000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2729898000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	673276000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	611688000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2107082000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2118210000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	245271000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	233141000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22347000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19291000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	84713000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	76895000	usd
CY2023Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	5004000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	43302000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	24063000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	16585000	usd
CY2023Q4	us-gaap	Assets Assets	2488480000	usd
CY2022Q4	us-gaap	Assets Assets	2507424000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1135051000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1147511000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	34304000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	25905000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	39069000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	39050000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	6009000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	5052000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1214433000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1217518000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9656000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9825000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43409841	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43409841	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43388742	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43388742	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	434000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	434000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1603757000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1599427000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2466844000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2331190000	usd
CY2023Q4	us-gaap	Cumulative Dividends CumulativeDividends	2817083000	usd
CY2022Q4	us-gaap	Cumulative Dividends CumulativeDividends	2660826000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1253952000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1270225000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	10439000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	9856000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1264391000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1280081000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2488480000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2507424000	usd
CY2023	us-gaap	Lease Income LeaseIncome	249227000	usd
CY2022	us-gaap	Lease Income LeaseIncome	217700000	usd
CY2021	us-gaap	Lease Income LeaseIncome	271049000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48809000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35796000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	21799000	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	24698000	usd
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	27666000	usd
CY2022	us-gaap	Revenues Revenues	278194000	usd
CY2021	us-gaap	Revenues Revenues	298715000	usd
CY2021	us-gaap	Depreciation Depreciation	80798000	usd
CY2023	us-gaap	Interest Expense InterestExpense	58160000	usd
CY2022	us-gaap	Interest Expense InterestExpense	44917000	usd
CY2021	us-gaap	Interest Expense InterestExpense	50810000	usd
CY2023	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	507000	usd
CY2023	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	449000	usd
CY2022	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	844000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19314000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22768000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18431000	usd
CY2023	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	11513000	usd
CY2022	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	9788000	usd
CY2021	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	11638000	usd
CY2023	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1376000	usd
CY2022	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	61911000	usd
CY2021	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	52766000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	200879000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	241856000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	216139000	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	20000	usd
CY2023	nhi	Gain Loss On Note Receivable Payoff GainLossOnNoteReceivablePayoff	0	usd
CY2022	nhi	Gain Loss On Note Receivable Payoff GainLossOnNoteReceivablePayoff	1113000	usd
CY2021	nhi	Gain Loss On Note Receivable Payoff GainLossOnNoteReceivablePayoff	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-151000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1912000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	555000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	569000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1545000	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	14721000	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	28342000	usd
CY2021	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	32498000	usd
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	202000	usd
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	0	usd
CY2021	us-gaap	Other Operating Income OtherOperatingIncome	350000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	135654000	usd
CY2023	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	57000	usd
CY2022	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	0	usd
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	135597000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	66403000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	111804000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388794	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44774708	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45714221	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43389466	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44794236	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45729497	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.48
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.45
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.44
CY2023	us-gaap	Profit Loss ProfitLoss	134381000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	65501000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	111967000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-137000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-7286000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7149000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	134381000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	65501000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	119116000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1273000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-902000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	163000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	135654000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	66403000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	118953000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	134381000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	65501000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	111967000	usd
CY2023	us-gaap	Depreciation Depreciation	69973000	usd
CY2022	us-gaap	Depreciation Depreciation	70880000	usd
CY2021	us-gaap	Depreciation Depreciation	80798000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4685000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4283000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4354000	usd
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	412000	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	872000	usd
CY2021	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	729000	usd
CY2023	nhi	Amortization Of Lease Inducement AmortizationOfLeaseInducement	2521000	usd
CY2022	nhi	Amortization Of Lease Inducement AmortizationOfLeaseInducement	7555000	usd
CY2021	nhi	Amortization Of Lease Inducement AmortizationOfLeaseInducement	1026000	usd
CY2023	us-gaap	Straight Line Rent StraightLineRent	6961000	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	-16681000	usd
CY2021	us-gaap	Straight Line Rent StraightLineRent	14603000	usd
CY2023	nhi	Noncash Rental Income NoncashRentalIncome	2500000	usd
CY2022	nhi	Noncash Rental Income NoncashRentalIncome	3000000	usd
CY2021	nhi	Noncash Rental Income NoncashRentalIncome	0	usd
CY2023	us-gaap	Other Noncash Income OtherNoncashIncome	1302000	usd
CY2022	us-gaap	Other Noncash Income OtherNoncashIncome	4314000	usd
CY2021	us-gaap	Other Noncash Income OtherNoncashIncome	2614000	usd
CY2023	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	0	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-8838000	usd
CY2021	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	0	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	14721000	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	28342000	usd
CY2021	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	32498000	usd
CY2023	nhi	Gain Loss On Note Payoff GainLossOnNotePayoff	0	usd
CY2022	nhi	Gain Loss On Note Payoff GainLossOnNotePayoff	1113000	usd
CY2021	nhi	Gain Loss On Note Payoff GainLossOnNotePayoff	0	usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-710000	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-151000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1912000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	555000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	569000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1545000	usd
CY2023	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1376000	usd
CY2022	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	61911000	usd
CY2021	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	52766000	usd
CY2023	nhi	Payment Of Tenant Lease Incentives PaymentOfTenantLeaseIncentives	10000000	usd
CY2022	nhi	Payment Of Tenant Lease Incentives PaymentOfTenantLeaseIncentives	1200000	usd
CY2021	nhi	Payment Of Tenant Lease Incentives PaymentOfTenantLeaseIncentives	1042000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4605000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8613000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8415000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2743000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3534000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4050000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5929000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	425000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3352000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	101000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	412000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	260000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	184450000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	185340000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	210859000	usd
CY2023	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	35625000	usd
CY2022	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	79801000	usd
CY2021	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	72236000	usd
CY2023	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	13465000	usd
CY2022	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	119212000	usd
CY2021	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	67790000	usd
CY2023	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	38081000	usd
CY2022	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	6364000	usd
CY2021	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	46817000	usd
CY2023	us-gaap	Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans	57031000	usd
CY2022	us-gaap	Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans	168958000	usd
CY2021	us-gaap	Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans	238864000	usd
CY2023	nhi	Payments To Renovate Real Estate PaymentsToRenovateRealEstate	7732000	usd
CY2022	nhi	Payments To Renovate Real Estate PaymentsToRenovateRealEstate	4629000	usd
CY2021	nhi	Payments To Renovate Real Estate PaymentsToRenovateRealEstate	3465000	usd
CY2023	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	3743000	usd
CY2022	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	0	usd
CY2021	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	64000	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	3055000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	569000	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	1205000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11630000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	197945000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	185277000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	364000000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	225000000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	95000000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	161000000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	183000000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	393000000	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	200000000	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	415427000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	135388000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	293316000	usd
CY2023	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	396784000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1462000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2747000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4612000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5018000	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1280000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	916000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	910000	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2973000	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	11738000	usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	288000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47904000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	66000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock	66076000	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	156238000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	161771000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	182900000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	151951000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-169719000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-401254000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-402994000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3101000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17969000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6858000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21516000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39485000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46343000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24617000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21516000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39485000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	51897000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	42659000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	43680000	usd
CY2023	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	14200000	usd
CY2022	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	23071000	usd
CY2021	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	0	usd
CY2023	nhi	Increase In Mortgage Note Receivable From Sale Of Real Estate IncreaseInMortgageNoteReceivableFromSaleOfRealEstate	2249000	usd
CY2022	nhi	Increase In Mortgage Note Receivable From Sale Of Real Estate IncreaseInMortgageNoteReceivableFromSaleOfRealEstate	0	usd
CY2021	nhi	Increase In Mortgage Note Receivable From Sale Of Real Estate IncreaseInMortgageNoteReceivableFromSaleOfRealEstate	0	usd
CY2023	nhi	Change In Other Assets Related To Sales Of Real Estate ChangeInOtherAssetsRelatedToSalesOfRealEstate	0	usd
CY2022	nhi	Change In Other Assets Related To Sales Of Real Estate ChangeInOtherAssetsRelatedToSalesOfRealEstate	102000	usd
CY2021	nhi	Change In Other Assets Related To Sales Of Real Estate ChangeInOtherAssetsRelatedToSalesOfRealEstate	-33000	usd
CY2023	nhi	Changein Accounts Payable Investmentsin Real Estate Construction ChangeinAccountsPayableInvestmentsinRealEstateConstruction	325000	usd
CY2022	nhi	Changein Accounts Payable Investmentsin Real Estate Construction ChangeinAccountsPayableInvestmentsinRealEstateConstruction	20000	usd
CY2021	nhi	Changein Accounts Payable Investmentsin Real Estate Construction ChangeinAccountsPayableInvestmentsinRealEstateConstruction	-62000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	101000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	nhi	Change In Accounts Payable Renovations Of Existing Real Estate ChangeInAccountsPayableRenovationsOfExistingRealEstate	0	usd
CY2022	nhi	Change In Accounts Payable Renovations Of Existing Real Estate ChangeInAccountsPayableRenovationsOfExistingRealEstate	-37000	usd
CY2021	nhi	Change In Accounts Payable Renovations Of Existing Real Estate ChangeInAccountsPayableRenovationsOfExistingRealEstate	0	usd
CY2023	nhi	Change In Accounts Payable Related To Distributions To Noncontrolling Interests ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests	6000	usd
CY2022	nhi	Change In Accounts Payable Related To Distributions To Noncontrolling Interests ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests	139000	usd
CY2021	nhi	Change In Accounts Payable Related To Distributions To Noncontrolling Interests ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests	64000	usd
CY2023	nhi	Operating Equipment Received In Transfer Of Operations OperatingEquipmentReceivedInTransferOfOperations	0	usd
CY2022	nhi	Operating Equipment Received In Transfer Of Operations OperatingEquipmentReceivedInTransferOfOperations	1287000	usd
CY2021	nhi	Operating Equipment Received In Transfer Of Operations OperatingEquipmentReceivedInTransferOfOperations	0	usd
CY2023	nhi	Capitalized Costs Transfer Of Operations CapitalizedCostsTransferOfOperations	0	usd
CY2022	nhi	Capitalized Costs Transfer Of Operations CapitalizedCostsTransferOfOperations	300000	usd
CY2021	nhi	Capitalized Costs Transfer Of Operations CapitalizedCostsTransferOfOperations	0	usd
CY2023	nhi	Reclassification Of Prepaid Equity Issuance Costs To Capital In Excess Of Par Value ReclassificationOfPrepaidEquityIssuanceCostsToCapitalInExcessOfParValue	275000	usd
CY2022	nhi	Reclassification Of Prepaid Equity Issuance Costs To Capital In Excess Of Par Value ReclassificationOfPrepaidEquityIssuanceCostsToCapitalInExcessOfParValue	0	usd
CY2021	nhi	Reclassification Of Prepaid Equity Issuance Costs To Capital In Excess Of Par Value ReclassificationOfPrepaidEquityIssuanceCostsToCapitalInExcessOfParValue	0	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1522945000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	974000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	119116000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-6076000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	47904000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1516983000	usd
CY2022	nhi	Distributions Attributable To Redeemable Noncontrolling Interest DistributionsAttributableToRedeemableNoncontrollingInterest	40000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1015000	usd
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-843000	usd
CY2022	nhi	Net Income Loss Excluding Gain Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossExcludingGainLossAttributableToRedeemableNoncontrollingInterest	66344000	usd
CY2022	nhi	Noncontrolling Interest Increase For Reclassification Of Redeemable Noncontrolling Interest NoncontrollingInterestIncreaseForReclassificationOfRedeemableNoncontrollingInterest	1030000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-80000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	288000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	151951000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8613000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.60
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	159555000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1280081000	usd
CY2023	nhi	Capital Contribution Attributable To Redeemable Noncontrolling Interest CapitalContributionAttributableToRedeemableNoncontrollingInterest	922000	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2051000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1286000	usd
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-1091000	usd
CY2023	nhi	Net Income Loss Excluding Gain Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossExcludingGainLossAttributableToRedeemableNoncontrollingInterest	135472000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-275000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4605000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.60
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	156257000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1264391000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q4	nhi	Number Of Real Estate Properties Classified As Held For Sale NumberOfRealEstatePropertiesClassifiedAsHeldForSale	1	property
CY2023Q4	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	8	mortgage
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	260700000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15500000	usd
CY2023Q4	nhi	Number Of Joint Ventures NumberOfJointVentures	2	jointventure
CY2023Q4	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant assumptions and estimates include purchase price allocations to record investments in real estate, impairment of real estate, and allowance for credit losses. Actual results could differ from those estimates.</span></div>
CY2023Q4	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19291000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37412000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2225000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	2073000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21516000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39485000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22347000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19291000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	2270000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2225000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24617000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21516000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our credit risks primarily relate to cash and cash equivalents and investments in mortgage and other notes receivable. Cash and cash equivalents are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that may exceed federally insured limits. We have not experienced any losses in such accounts. Our mortgages and other notes receivable consist primarily of secured loans on facilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments, principally our investments in notes receivable, are subject to the possibility of loss of the carrying values as a result of the failure of other parties to perform according to their contractual obligations which may make the instruments less valuable. We obtain collateral in the form of mortgage liens and other protective rights for notes receivable and continually monitor these rights in order to reduce such possibilities of loss. We evaluate the need to provide for reserves for potential losses on our financial instruments based on management’s periodic review of our portfolio on an instrument-by-instrument basis.</span></div>
CY2023	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rental Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our leases generally provide for rent escalators throughout the term of the lease. Base rental income is recognized using the straight-line method over the term of the lease to the extent that lease payments are considered collectible and the lease provides for specific contractual escalators. Under certain leases, we receive additional contingent rent, which is calculated on the increase in revenues of the tenant over a target threshold. We recognize contingent rent periodically based on the actual revenues of the tenant once the target threshold has been achieved. Lease payments that depend on a factor directly related to future use of the property, such as an increase in annual revenues over a base year, are considered to be contingent rent payments and are excluded from the determination of minimum lease payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If rental income calculated on a straight-line basis exceeds the cash rent due under a lease, the difference is recorded as an increase to straight-line rents receivable in the Consolidated Balance Sheets and an increase in rental income in the Consolidated Statements of Income. If rental income on a straight-line basis is calculated to be less than cash received, there is a decrease in the same accounts.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property operating expenses that are reimbursed by our operators are recorded as “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rental income” </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Consolidated Statements of Income. Accordingly, we record a corresponding expense, reflected in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxes and insurance on leased properties” </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Consolidated Statements of Income. Rental income includes reimbursement of property operating expenses for the years ended December 2023, 2022 and 2021, totaling $11.5 million, $9.8 million and $11.6 million, respectively.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rental income is reduced for the non-cash amortization of payments made upon the eventual settlement of commitments and contingencies originally identified and recorded as lease inducements. We record lease inducements to the extent that it is probable that a significant reversal of amounts recognized will not occur when the uncertainty associated with the contingent consideration is subsequently resolved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its operating lease receivables for collectability on a regular basis, taking into consideration changes in factors such as the tenant’s payment history, the financial condition of the tenant, business conditions in which the tenant operates and economic conditions in the area where the property is located. In the event that collectability with respect to any tenant is not probable, a direct write-off of the receivable is made as an adjustment to rental income and any future rental revenue is recognized only when the tenant makes a rental payment. As of December 31, 2023, we had three tenants, including </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bickford Senior Living (“Bickford”), on the cash basis of revenue recognition for their lease arrangements. During the year ended December 31, 2022, we placed three operators on the cash basis of rental income recognition. During the year ended December 31, 2021, we placed Holiday Retirement (“Holiday”) on cash basis for its master lease which was terminated in 2022 upon the formation of the SHOP ventures. Reference Note 3 for further discussion of cash basis tenants.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Resident Fees and Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Resident fee and services revenue associated with our SHOP activities is recognized as the related performance obligations are satisfied and includes resident room charges, community fees and other resident charges. </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Residency agreements are generally short term (30 days to one year), and entitle the resident to certain room and care services for a monthly fee billed in advance. Revenue for certain related services is billed monthly in arrears. The Company has elected the lessor practical expedient within ASC Topic 842, Leases, not to separate the lease and nonlease components within our resident agreements as the timing and pattern of transfer to the resident are the same. The Company has determined that the nonlease component is the predominant component within the contract and will recognize revenue under ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>
CY2023Q4	nhi	Number Of Tenants Cash Basis Revenue Recognition NumberOfTenantsCashBasisRevenueRecognition	3	tenant
CY2023	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from Mortgage and Other Notes Receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Interest income is recognized based on the interest rates and principal amounts outstanding on the notes receivable. We identify a mortgage note as non-performing based on various criteria including timeliness of required payments, compliance with other provisions under the related note agreement, and an evaluation of the borrower’s current financial condition for indicators that it is probable it cannot pay its contractual amounts. A non-performing loan is returned to accrual status at such time as the note becomes contractually current and management believes all future principal and interest will be received according to the contractual terms of the note. As of December 31, 2023, we had two mortgage notes receivable and a mezzanine loan totaling an aggregate of $26.6 million with affiliates of two operators/borrowers, including Bickford, designated as non-performing.</span></div>
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	14200000	usd
CY2022Q2	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	9100000	usd
CY2023Q4	nhi	Number Of Real Estate Properties Classified As Held For Sale NumberOfRealEstatePropertiesClassifiedAsHeldForSale	1	property
CY2022Q4	nhi	Number Of Real Estate Properties Classified As Held For Sale NumberOfRealEstatePropertiesClassifiedAsHeldForSale	13	property
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	5004000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	43302000	usd
CY2023Q4	us-gaap	Real Estate Assets Held For Development And Sale RealEstateAssetsHeldForDevelopmentAndSale	500000	usd
CY2023	nhi	Number Of Real Estate Properties Impaired Sold Or Classified As Held For Sale NumberOfRealEstatePropertiesImpairedSoldOrClassifiedAsHeldForSale	3	property
CY2023Q4	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	2600000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15500000	usd
CY2023	nhi	Operating Lease Lease Income Escrow Funds OperatingLeaseLeaseIncomeEscrowFunds	11513000	usd
CY2022	nhi	Operating Lease Lease Income Escrow Funds OperatingLeaseLeaseIncomeEscrowFunds	9788000	usd
CY2021	nhi	Operating Lease Lease Income Escrow Funds OperatingLeaseLeaseIncomeEscrowFunds	11638000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2430413000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	260747000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48809000	usd
CY2023	nhi	Percentage Of Continuing Revenue PercentageOfContinuingRevenue	0.15
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35796000	usd
CY2022	nhi	Percentage Of Continuing Revenue PercentageOfContinuingRevenue	0.13
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2021	nhi	Percentage Of Continuing Revenue PercentageOfContinuingRevenue	0
CY2023	us-gaap	Revenues Revenues	319835000	usd
CY2022	us-gaap	Revenues Revenues	278194000	usd
CY2021	us-gaap	Revenues Revenues	298715000	usd
CY2023Q4	nhi	Number Of Board Of Directors Members Also Members Of Nhc Board Of Directors NumberOfBoardOfDirectorsMembersAlsoMembersOfNHCBoardOfDirectors	2	boardmember
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2500000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1300000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1562000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1599000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1705000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1724000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	232059000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	237981000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	244581000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	198598000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	192179000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	684840000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1790238000	usd
CY2021	nhi	Operating Lease Lease Income Escrow Funds OperatingLeaseLeaseIncomeEscrowFunds	11638000	usd
CY2023	us-gaap	Lease Income LeaseIncome	249227000	usd
CY2022	us-gaap	Lease Income LeaseIncome	217700000	usd
CY2021	us-gaap	Lease Income LeaseIncome	271049000	usd
CY2023Q4	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	16	property
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15500000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15300000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15476000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	245271000	usd
CY2023Q4	nhi	Probability Of Default Increase Current Conditions Adjustment ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment	0.20
CY2023Q4	nhi	Probability Of Default Increase Current Conditions Adjustment ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment	0.20
CY2023Q4	nhi	Estimated Credit Losses Current Conditions Adjustment Combined EstimatedCreditLossesCurrentConditionsAdjustmentCombined	0.44
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15338000	usd
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	138000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15476000	usd
CY2023Q4	nhi	Annual Fixed Preferred Return AnnualFixedPreferredReturn	10200000	usd
CY2023Q2	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	4600000	usd
CY2023Q4	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	2600000	usd
CY2023Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	-5000000	usd
CY2023	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	2700000	usd
CY2022	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-4200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
CY2023	nhi	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2	extensionoption
CY2023Q4	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	11800000	usd
CY2023Q4	us-gaap	Incentive To Lessee IncentiveToLessee	10669000	usd
CY2022Q4	us-gaap	Incentive To Lessee IncentiveToLessee	3190000	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	6208000	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	6208000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	2270000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2225000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	24063000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	16585000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	245000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	42000000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8912000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8538000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1135051000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1147511000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	75425000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	325816000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	245000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	100000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	400000000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1146241000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2278000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8912000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1135051000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	2700000	usd
CY2023Q2	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	220000000	usd
CY2023	nhi	Debt Leverage Limit Coupon Change Trigger DebtLeverageLimitCouponChangeTrigger	0.50
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	55603000	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	42487000	usd
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	40866000	usd
CY2023	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	0	usd
CY2022	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	0	usd
CY2021	us-gaap	Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	7286000	usd
CY2023	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	90000	usd
CY2022	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	46000	usd
CY2021	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	40000	usd
CY2023	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	2647000	usd
CY2022	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	2476000	usd
CY2021	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	2698000	usd
CY2023	us-gaap	Interest Expense InterestExpense	58160000	usd
CY2022	us-gaap	Interest Expense InterestExpense	44917000	usd
CY2021	us-gaap	Interest Expense InterestExpense	50810000	usd
CY2023	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	130725000	usd
CY2023Q4	nhi	Notes Receivable Funding Commitment NotesReceivableFundingCommitment	41398000	usd
CY2023	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	-404000	usd
CY2023Q4	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	279000	usd
CY2023Q4	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	14515000	usd
CY2023Q4	us-gaap	Development In Process DevelopmentInProcess	10955000	usd
CY2023Q4	nhi	Remaining Unfunded Development Commitment RemainingUnfundedDevelopmentCommitment	3560000	usd
CY2023Q4	nhi	Contingent Funding Commitment ContingentFundingCommitment	11600000	usd
CY2023Q4	nhi	Contingent Funding Commitment Amount Funded ContingentFundingCommitmentAmountFunded	2700000	usd
CY2023Q4	nhi	Contingent Funding Commitment Remaining Unfunded Amount ContingentFundingCommitmentRemainingUnfundedAmount	8900000	usd
CY2022Q1	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	6900000	usd
CY2022Q2	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	6900000	usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-700000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9825000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	usd
CY2023	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	0	usd
CY2022	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	11738000	usd
CY2023	nhi	Temporary Equity Decrease From Reclassification TemporaryEquityDecreaseFromReclassification	0	usd
CY2022	nhi	Temporary Equity Decrease From Reclassification TemporaryEquityDecreaseFromReclassification	1030000	usd
CY2023	nhi	Contributions Attributable To Redeemable Noncontrolling Interest ContributionsAttributableToRedeemableNoncontrollingInterest	922000	usd
CY2022	nhi	Contributions Attributable To Redeemable Noncontrolling Interest ContributionsAttributableToRedeemableNoncontrollingInterest	0	usd
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-1091000	usd
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-843000	usd
CY2023	nhi	Distributions Attributable To Redeemable Noncontrolling Interest DistributionsAttributableToRedeemableNoncontrollingInterest	0	usd
CY2022	nhi	Distributions Attributable To Redeemable Noncontrolling Interest DistributionsAttributableToRedeemableNoncontrollingInterest	40000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9656000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9825000	usd
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2468354	shares
CY2022	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	61.56
CY2020Q1	nhi	At The Market Shelf Registration Equity Offering Sales Agreement Aggregate Sales Price AtTheMarketShelfRegistrationEquityOfferingSalesAgreementAggregateSalesPrice	500000000	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	661951	shares
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	73.62
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47900000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2023Q4	nhi	Share Based Payment Arrangement Number Of Incentive Plans ShareBasedPaymentArrangementNumberOfIncentivePlans	2	plan
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4605000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8613000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8415000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.56
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.92
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.54
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.069
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.070
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.067
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.390
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.493
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.481
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0456
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0175
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0033
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1033838	shares
CY2020Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	83.54
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1652505	shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	74498	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	77.93
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2216175	shares
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	70.97
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5166	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	53.41
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	61168	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	88170	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	64.33
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2447171	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	68.80
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y3M3D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2078827	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	71.40
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2447171	shares
CY2022Q4	nhi	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedNumber	515020	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	12.51
CY2023Q4	nhi	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedNumber	368344	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	11.48
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1800000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1900000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1300000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
CY2023	nhi	Aggregate Intrinsic Value Per Share Options Exercised AggregateIntrinsicValuePerShareOptionsExercised	1.23
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
CY2022	nhi	Aggregate Intrinsic Value Per Share Options Exercised AggregateIntrinsicValuePerShareOptionsExercised	6.13
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	usd
CY2021	nhi	Aggregate Intrinsic Value Per Share Options Exercised AggregateIntrinsicValuePerShareOptionsExercised	9.27
CY2023	us-gaap	Profit Loss ProfitLoss	134381000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	65501000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	111967000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1273000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-902000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	163000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	135654000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	66403000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	111804000	usd
CY2023	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	57000	usd
CY2022	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	0	usd
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	135597000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	66403000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	111804000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388794	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44774708	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45714221	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43388794	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	44774708	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45714221	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	672	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	19528	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4823	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	10453	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43389466	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44794236	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45729497	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.48
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.45
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.44
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	802506	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	564803	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	383716	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.60
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.60
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.8025
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1500000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.60
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.60
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.8025
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	operatingsegment
CY2023	us-gaap	Lease Income LeaseIncome	249227000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48809000	usd
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	21799000	usd
CY2023	us-gaap	Revenues Revenues	319835000	usd
CY2023	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	39587000	usd
CY2023	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	11513000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	268735000	usd
CY2023	us-gaap	Depreciation Depreciation	69973000	usd
CY2023	us-gaap	Interest Expense InterestExpense	58160000	usd
CY2023	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	507000	usd
CY2023	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	449000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19314000	usd
CY2023	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1376000	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	14721000	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	20000	usd
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	202000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	555000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	134381000	usd
CY2023Q4	us-gaap	Assets Assets	2488480000	usd
CY2022	us-gaap	Lease Income LeaseIncome	217700000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35796000	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	24698000	usd
CY2022	us-gaap	Revenues Revenues	278194000	usd
CY2022	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	28193000	usd
CY2022	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	9788000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	240213000	usd
CY2022	us-gaap	Depreciation Depreciation	70880000	usd
CY2022	us-gaap	Interest Expense InterestExpense	44917000	usd
CY2022	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	2555000	usd
CY2022	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	844000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22768000	usd
CY2022	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	61911000	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	28342000	usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-710000	usd
CY2022	nhi	Gain Loss On Note Receivable Payoff GainLossOnNoteReceivablePayoff	1113000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-151000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	569000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	65501000	usd
CY2022Q4	us-gaap	Assets Assets	2507424000	usd
CY2023Q4	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	243
CY2023Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	76241000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	180749000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	2537123000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Improvements RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImprovements	62486000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	180749000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	2599609000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2780358000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	673276000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P40Y
CY2023Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	2100000000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2729898000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2894548000	usd
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	3265070000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49556000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10993000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	50346000	usd
CY2023	nhi	Sec Schedule1228 Change In Accounts Payable Real Property And Equipment Additions SECSchedule1228ChangeInAccountsPayableRealPropertyAndEquipmentAdditions	325000	usd
CY2022	nhi	Sec Schedule1228 Change In Accounts Payable Real Property And Equipment Additions SECSchedule1228ChangeInAccountsPayableRealPropertyAndEquipmentAdditions	-69000	usd
CY2021	nhi	Sec Schedule1228 Change In Accounts Payable Real Property And Equipment Additions SECSchedule1228ChangeInAccountsPayableRealPropertyAndEquipmentAdditions	-388000	usd
CY2023	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate And Accumulated Depreciation Change In Other Assets Related To Investment In Real Estate SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAndAccumulatedDepreciationChangeInOtherAssetsRelatedToInvestmentInRealEstate	454000	usd
CY2022	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate And Accumulated Depreciation Change In Other Assets Related To Investment In Real Estate SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAndAccumulatedDepreciationChangeInOtherAssetsRelatedToInvestmentInRealEstate	200000	usd
CY2021	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate And Accumulated Depreciation Change In Other Assets Related To Investment In Real Estate SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAndAccumulatedDepreciationChangeInOtherAssetsRelatedToInvestmentInRealEstate	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	101000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	usd
CY2022	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	1287000	usd
CY2021	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	usd
CY2023	nhi	Additions Acquired Through Exchange Of Non Cash Rental Income AdditionsAcquiredThroughExchangeOfNonCashRentalIncome	2500000	usd
CY2022	nhi	Additions Acquired Through Exchange Of Non Cash Rental Income AdditionsAcquiredThroughExchangeOfNonCashRentalIncome	3000000	usd
CY2021	nhi	Additions Acquired Through Exchange Of Non Cash Rental Income AdditionsAcquiredThroughExchangeOfNonCashRentalIncome	0	usd
CY2023	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	14200000	usd
CY2022	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	23071000	usd
CY2021	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	0	usd
CY2023	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	19326000	usd
CY2022	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	104691000	usd
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	276429000	usd
CY2023	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Property Classified As Held For Use SECSchedule1228RealEstateCompaniesInvestmentInRealEstatePropertyClassifiedAsHeldForUse	11970000	usd
CY2022	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Property Classified As Held For Use SECSchedule1228RealEstateCompaniesInvestmentInRealEstatePropertyClassifiedAsHeldForUse	84761000	usd
CY2021	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Property Classified As Held For Use SECSchedule1228RealEstateCompaniesInvestmentInRealEstatePropertyClassifiedAsHeldForUse	137651000	usd
CY2023	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Property Reclassified As Held For Use SECSchedule1228RealEstateCompaniesInvestmentInRealEstatePropertyReclassifiedAsHeldForUse	15793000	usd
CY2022	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Property Reclassified As Held For Use SECSchedule1228RealEstateCompaniesInvestmentInRealEstatePropertyReclassifiedAsHeldForUse	7851000	usd
CY2021	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Property Reclassified As Held For Use SECSchedule1228RealEstateCompaniesInvestmentInRealEstatePropertyReclassifiedAsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	1173000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	21531000	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	6400000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2780358000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2729898000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2894548000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	611688000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	576668000	usd
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	597638000	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	69973000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	70880000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	80798000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	38000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	36000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	36000	usd
CY2023	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Sale Of Properties SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationSaleOfProperties	4851000	usd
CY2022	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Sale Of Properties SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationSaleOfProperties	25643000	usd
CY2021	nhi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Sale Of Properties SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationSaleOfProperties	70063000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	6965000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	11092000	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	31741000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Other Additions RealEstateAccumulatedDepreciationOtherAdditions	3393000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Other Additions RealEstateAccumulatedDepreciationOtherAdditions	839000	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Other Additions RealEstateAccumulatedDepreciationOtherAdditions	0	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	673276000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	611688000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	576668000	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	162433000	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Principal Amount Of Delinquent Loans MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans	0	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Federal Income Tax Basis1 MortgageLoansOnRealEstateFederalIncomeTaxBasis1	175200000	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	32500	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	164576000	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	230927000	usd
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	259491000	usd
CY2023	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	15083000	usd
CY2022	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	67978000	usd
CY2021	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	33160000	usd
CY2023	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Amortization Of Loan Discount And Commitment Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAmortizationOfLoanDiscountAndCommitmentFees	428000	usd
CY2022	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Amortization Of Loan Discount And Commitment Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAmortizationOfLoanDiscountAndCommitmentFees	907000	usd
CY2021	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Amortization Of Loan Discount And Commitment Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAmortizationOfLoanDiscountAndCommitmentFees	741000	usd
CY2023	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Additions SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAdditions	15511000	usd
CY2022	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Additions SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAdditions	68885000	usd
CY2021	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Additions SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAdditions	33901000	usd
CY2023	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Fees Received SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateFeesReceived	0	usd
CY2022	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Fees Received SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateFeesReceived	497000	usd
CY2021	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Fees Received SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateFeesReceived	0	usd
CY2023	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Real Estate Investments SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateRealEstateInvestments	-14200000	usd
CY2022	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Real Estate Investments SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateRealEstateInvestments	-23071000	usd
CY2021	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Real Estate Investments SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateRealEstateInvestments	0	usd
CY2023	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	3454000	usd
CY2022	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	111668000	usd
CY2021	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	62465000	usd
CY2023	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Deductions SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeductions	17654000	usd
CY2022	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Deductions SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeductions	135236000	usd
CY2021	nhi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Deductions SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeductions	62465000	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	162433000	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	164576000	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	230927000	usd

Files In Submission

Name	View Source	Status
0000877860-24-000010-index-headers.html	Edgar Link	pending
0000877860-24-000010-index.html	Edgar Link	pending
0000877860-24-000010.txt	Edgar Link	pending
0000877860-24-000010-xbrl.zip	Edgar Link	pending
descriptionofsecurities.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nationalhealthinvestorsinc.htm	Edgar Link	pending
nhi-12312023x10kex21.htm	Edgar Link	pending
nhi-12312023x10kex231.htm	Edgar Link	pending
nhi-12312023x10kex311.htm	Edgar Link	pending
nhi-12312023x10kex312.htm	Edgar Link	pending
nhi-12312023x10kex32.htm	Edgar Link	pending
nhi-20231231.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nhi-20231231.xsd	Edgar Link	pending
nhi-20231231_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
nhi-20231231_def.xml	Edgar Link	unprocessable
nhi-20231231_htm.xml	Edgar Link	completed
nhi-20231231_lab.xml	Edgar Link	unprocessable
nhi-20231231_pre.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nhi-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

2024 Q1 Form 10-K Financial Statement

#000087786024000010 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI NATIONAL HEALTH INVESTORS INC Stock $nhi

2024 Q1 Form 10-K Financial Statement

#000087786024000010 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi